• Je něco špatně v tomto záznamu ?

Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana

E. Schadich, S. Nylén, S. Gurská, J. Kotulová, S. Andronati, V. Pavlovsky, S. Soboleva, P. Polishchuk, M. Hajdúch, P. Džubák

. 2022 ; 91 (-) : 102647. [pub] 20220817

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024167

A series of 1-aryl-4-(phthalimidoalkyl) piperazines and 1-aryl-4-(naphthalimidoalkyl) piperazines were retrieved from a proprietary library based on their high structural similarity to haloperidol, an antipsychotic with antiparasitic activity, and assessed as potential antileishmanial scaffolds. Selected compounds were tested for antileishmanial activity against promastigotes of Leishmania major and Leishmania mexicana in dose-response assays. Two of the 1-aryl-4-(naphthalimidoalkyl) piperazines (compounds 10 and 11) were active against promastigotes of both Leishmania species without being toxic to human fibroblasts. Their activity was found to correlate with the length of their alkyl chains. Further analyses showed that compound 11 was also active against intracellular amastigotes of both Leishmania species. In promastigotes of both Leishmania species, compound 11 induced collapse of the mitochondrial electrochemical potential and increased the intracellular Ca2+ concentration. Therefore, it may serve as a promising lead compound for the development of novel antiparasitic drugs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024167
003      
CZ-PrNML
005      
20221031100449.0
007      
ta
008      
221017s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.parint.2022.102647 $2 doi
035    __
$a (PubMed)35985636
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Schadich, Ermin $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and University Hospital, Palacky University Olomouc, Czech Republic
245    10
$a Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana / $c E. Schadich, S. Nylén, S. Gurská, J. Kotulová, S. Andronati, V. Pavlovsky, S. Soboleva, P. Polishchuk, M. Hajdúch, P. Džubák
520    9_
$a A series of 1-aryl-4-(phthalimidoalkyl) piperazines and 1-aryl-4-(naphthalimidoalkyl) piperazines were retrieved from a proprietary library based on their high structural similarity to haloperidol, an antipsychotic with antiparasitic activity, and assessed as potential antileishmanial scaffolds. Selected compounds were tested for antileishmanial activity against promastigotes of Leishmania major and Leishmania mexicana in dose-response assays. Two of the 1-aryl-4-(naphthalimidoalkyl) piperazines (compounds 10 and 11) were active against promastigotes of both Leishmania species without being toxic to human fibroblasts. Their activity was found to correlate with the length of their alkyl chains. Further analyses showed that compound 11 was also active against intracellular amastigotes of both Leishmania species. In promastigotes of both Leishmania species, compound 11 induced collapse of the mitochondrial electrochemical potential and increased the intracellular Ca2+ concentration. Therefore, it may serve as a promising lead compound for the development of novel antiparasitic drugs.
650    _2
$a antiparazitární látky $7 D000977
650    12
$a antiprotozoální látky $x chemie $x farmakologie $7 D000981
650    _2
$a lidé $7 D006801
650    12
$a Leishmania major $7 D018320
650    12
$a Leishmania mexicana $7 D007894
650    _2
$a piperaziny $x farmakologie $7 D010879
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nylén, Susanne $u Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
700    1_
$a Gurská, Soňa $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and University Hospital, Palacky University Olomouc, Czech Republic
700    1_
$a Kotulová, Jana $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and University Hospital, Palacky University Olomouc, Czech Republic
700    1_
$a Andronati, Sergey $u A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine, Odessa, Ukraine
700    1_
$a Pavlovsky, Victor $u A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine, Odessa, Ukraine
700    1_
$a Soboleva, Svetlana $u I.I. Mechnikova Odessa National University, Odessa, Ukraine
700    1_
$a Polishchuk, Pavel $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and University Hospital, Palacky University Olomouc, Czech Republic
700    1_
$a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and University Hospital, Palacky University Olomouc, Czech Republic
700    1_
$a Džubák, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and University Hospital, Palacky University Olomouc, Czech Republic. Electronic address: petr.dzubak@upol.cz
773    0_
$w MED00008651 $t Parasitology international $x 1873-0329 $g Roč. 91, č. - (2022), s. 102647
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35985636 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100447 $b ABA008
999    __
$a ok $b bmc $g 1854097 $s 1175457
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 91 $c - $d 102647 $e 20220817 $i 1873-0329 $m Parasitology international $n Parasitol Int $x MED00008651
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace